Patent: 6,489,542
✉ Email this page to a colleague
Summary for Patent: 6,489,542
Title: | Methods for transforming plants to express Cry2Ab .delta.-endotoxins targeted to the plastids |
Abstract: | Disclosed is a means of controlling plant pests by a novel method of expressing Cry2Ab B. thuringiensis .delta.-endotoxins in plants, targeted to the plastids. The invention comprises novel nucleic acid segments encoding proteins comprising Cry2Ab B. thuringiensis .delta.-endotoxins. The nucleic acid segments are disclosed, as are transformation vectors containing the nucleic acid segments, plants transformed with the claimed segments, methods for transforming plants, and methods of controlling plant infestation by pests. |
Inventor(s): | Corbin; David R. (Chesterfield, MO), Romano; Charles P. (Medfield, MA) |
Assignee: | Monsanto Technology LLC (St. Louis, MO) |
Application Number: | 09/186,002 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,489,542 |
Patent Claims: | see list of patent claims |
Details for Patent 6,489,542
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2039-02-26 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2039-02-26 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2039-02-26 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |